CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. So when we looked at CareCloud (NASDAQ:CCLD) and its trend of ROCE, we really liked what we saw.

Advertisement

Understanding Return On Capital Employed (ROCE)

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for CareCloud, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.11 = US$5.2m ÷ (US$71m - US$22m) (Based on the trailing twelve months to September 2024).

So, CareCloud has an ROCE of 11%. In absolute terms, that's a satisfactory return, but compared to the Healthcare Services industry average of 6.8% it's much better.

View our latest analysis for CareCloud

roce
NasdaqGM:CCLD Return on Capital Employed February 19th 2025

In the above chart we have measured CareCloud's prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering CareCloud for free.

What Does the ROCE Trend For CareCloud Tell Us?

The fact that CareCloud is now generating some pre-tax profits from its prior investments is very encouraging. The company was generating losses five years ago, but now it's earning 11% which is a sight for sore eyes. Not only that, but the company is utilizing 21% more capital than before, but that's to be expected from a company trying to break into profitability. This can tell us that the company has plenty of reinvestment opportunities that are able to generate higher returns.

What We Can Learn From CareCloud's ROCE

In summary, it's great to see that CareCloud has managed to break into profitability and is continuing to reinvest in its business. Given the stock has declined 40% in the last five years, this could be a good investment if the valuation and other metrics are also appealing. With that in mind, we believe the promising trends warrant this stock for further investigation.

One more thing, we've spotted 4 warning signs facing CareCloud that you might find interesting.

While CareCloud may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGM:CCLD

CareCloud

A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.672.0% undervalued
28 users have followed this narrative
0 users have commented on this narrative
18 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.233.9% undervalued
55 users have followed this narrative
1 users have commented on this narrative
19 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2686.6% undervalued
34 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3413.0% undervalued
6 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

CG
CG86
BLCO logo
CG86 on Bausch + Lomb ·

$BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE!

Fair Value:US$39.2357.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ST
StructuredAlpha
IREN logo
StructuredAlpha on IREN ·

IREN Thesis: From Miner to AI Infrastructure Leader

Fair Value:US$7031.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
HedgeY
NEXA logo
HedgeY on Nexa Resources ·

Nexa; an integrated base-metals platform with real cash-flow torque?

Fair Value:US$156.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3957.0% overvalued
52 users have followed this narrative
3 users have commented on this narrative
43 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$579.5727.1% undervalued
1367 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.233.9% undervalued
55 users have followed this narrative
1 users have commented on this narrative
19 users have liked this narrative

Trending Discussion

SP
EOSE logo
spearfishingcap on Eos Energy Enterprises ·

AI Slop

1
|
0
MA
BBW logo
manunogueira on Build-A-Bear Workshop ·

Why so high p/e?

0
|
0